These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1382813

  • 1. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD, Katz JL, Ricaurte GA.
    Brain Res; 1992 Sep 04; 589(2):349-52. PubMed ID: 1382813
    [Abstract] [Full Text] [Related]

  • 2. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May 04; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 3. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb 04; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 4. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 5. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 29; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 6. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul 29; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 7. N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats.
    Glennon RA, Young R, Dukat M, Chang-Fong J, El-Zahabi M.
    Pharmacol Biochem Behav; 2007 Mar 29; 86(3):477-84. PubMed ID: 17307247
    [Abstract] [Full Text] [Related]

  • 8. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
    Callaghan PD, Farrand K, Salem A, Hughes P, Daws LC, Irvine RJ.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):74-81. PubMed ID: 16925993
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: a comparative study using in vivo microdialysis.
    Matsumoto T, Maeno Y, Kato H, Seko-Nakamura Y, Monma-Ohtaki J, Ishiba A, Nagao M, Aoki Y.
    Eur Neuropsychopharmacol; 2014 Aug 28; 24(8):1362-70. PubMed ID: 24862256
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 28; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 13. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
    Brodkin J, Malyala A, Nash JF.
    Pharmacol Biochem Behav; 1993 Jul 28; 45(3):647-53. PubMed ID: 8101380
    [Abstract] [Full Text] [Related]

  • 14. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun 28; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
    Gough B, Imam SZ, Blough B, Slikker W, Ali SF.
    Ann N Y Acad Sci; 2002 Jun 28; 965():410-20. PubMed ID: 12105116
    [Abstract] [Full Text] [Related]

  • 16. Effect of PMA optical isomers and 4-MTA in PMMA-trained rats.
    Dukat M, Young R, Glennon RA.
    Pharmacol Biochem Behav; 2002 May 28; 72(1-2):299-305. PubMed ID: 11900800
    [Abstract] [Full Text] [Related]

  • 17. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A, Salem A, Irvine RJ.
    Brain Res; 2005 Apr 11; 1041(1):48-55. PubMed ID: 15804499
    [Abstract] [Full Text] [Related]

  • 18. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
    Johnson MP, Huang XM, Nichols DE.
    Pharmacol Biochem Behav; 1991 Dec 11; 40(4):915-22. PubMed ID: 1726189
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI, Green AR.
    Br J Pharmacol; 1994 Jan 11; 111(1):131-6. PubMed ID: 7516800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.